Dextromethorphan in Fibromyalgia

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
The objective of this protocol is to evaluate if Dextromethorphan (DXM) reduces Fibromyalgia (FM) pain. DXM is a drug found in several over-the-counter products, including cough suppressants. The drug may reduce FM pain by suppressing inflammation in the central nervous system. The investigators will be observing the effects of DXM on daily self-reported pain measures in people with FM. If DXM reduces FM pain, it will provide important information about the nature of FM pathophysiology.
Epistemonikos ID: 5b349897abb6b19c3987478690f4396d7cfc7866
First added on: May 21, 2024